NCT05325671 is a NA clinical trial of transarticular multimodal drug infiltration in Pain, Post Operative, sponsored by Department of Medical Services Ministry of Public Health of Thailand.

Who is sponsoring NCT05325671?

NCT05325671 is sponsored by Department of Medical Services Ministry of Public Health of Thailand.

What drugs are being tested in NCT05325671?

Interventions in NCT05325671: transarticular multimodal drug infiltration.

What condition does NCT05325671 study?

NCT05325671 studies Pain, Post Operative, Arthroplasty Complications.

Is NCT05325671 still recruiting?

NCT05325671 is currently completed. Last updated 25 January 2024.

Last reviewed 2024-01-25 · How we verify

NCT05325671

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial

Completed NA Last updated 25 January 2024

What this trial tests

NA trial testing transarticular multimodal drug infiltration in Pain, Post Operative in 120 participants. Completed in 31 October 2023.

Timeline

5 April 2022

Primary endpoint
30 September 2023

31 October 2023

Quick facts

Lead sponsor	Department of Medical Services Ministry of Public Health of Thailand
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	120
Start date	5 April 2022
Primary completion	30 September 2023
Estimated completion	31 October 2023
Sites	1 location across Thailand

Drugs / interventions tested

transarticular multimodal drug infiltration

Conditions studied

Pain, Post Operative — all drugs for Pain, Post Operative →
Arthroplasty Complications — all drugs for Arthroplasty Complications →

Sponsor

Department of Medical Services Ministry of Public Health of Thailand

Who can join

Adults 45 to 60, any sex, with Pain, Post Operative or Arthroplasty Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aim to improve postoperative outcome in total hip arthroplasty(THA) by using local mixture infiltration as bupivacaine + NSAID + epinephrine + tranxemic acid. In the present time these mixture components has shown to improve THA outcome by aspect of postoperative pain control, postoperative opioid consumption, postoperative bleeding, LOS and postoperative rehabilitation without increasing complication but the accuracy of infiltration technique which gives the best outcome has not been yet discovered.Recently study by Hashimoto et al has risen that these technique can be administrated by both periarticular and intra-articular approach.By considering the complexity of human anatomy around the hip tissue we assume that the intra-articular(transarticular) may given equivalence (may be better) outcome with lowering procedural related complication comparing to periarticular infiltration approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Post Operative

Currently open trials in the same condition.

NCT06671002 — Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial · Phase 4 · recruiting
NCT05146778 — A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia · NA · recruiting

Other Department of Medical Services Ministry of Public Health of Thailand trials

Trials by the same sponsor.

NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05325671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
Last refreshed: 25 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05325671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing